BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26105485)

  • 1. PP164. Magnesium sulphate for prevention and treatment of eclampsia in low and middle income countries: Systematic review of tested regimens.
    Gordon RM; Payne B; Firoz T; Magee L; Sawchuck D; Tu D; Vidler M; von Dadelszen P;
    Pregnancy Hypertens; 2012 Jul; 2(3):328. PubMed ID: 26105485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.
    Gordon R; Magee LA; Payne B; Firoz T; Sawchuck D; Tu D; Vidler M; de Silva D; von Dadelszen P
    J Obstet Gynaecol Can; 2014 Feb; 36(2):154-163. PubMed ID: 24518915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose magnesium sulphate in the control of eclamptic fits: a randomized controlled trial.
    Abdul MA; Nasir UI; Khan N; Yusuf MD
    Arch Gynecol Obstet; 2013 Jan; 287(1):43-6. PubMed ID: 22930148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial to compare acceptability of magnesium sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care.
    Ononge S; Nakimuli A; Byamugisha J; Adroma M; Kiondo P; Easterling T; Bracken H
    PLoS One; 2024; 19(6):e0286361. PubMed ID: 38865319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.
    Okusanya BO; Oladapo OT; Long Q; Lumbiganon P; Carroli G; Qureshi Z; Duley L; Souza JP; Gülmezoglu AM
    BJOG; 2016 Feb; 123(3):356-66. PubMed ID: 26599617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intramuscular loading dose of MgSO4 in severe pre-eclampsia/ eclampsia at a tertiary referral centre in Northwest Nigeria.
    Okusanya BO; Garba KD; Ibrahim HM
    Niger Postgrad Med J; 2012 Jun; 19(2):77-82. PubMed ID: 22728971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of low dose intramuscular magnesium sulphate (MgSO4) compared to intravenous regimen for treatment of eclampsia.
    Saha PK; Kaur J; Goel P; Kataria S; Tandon R; Saha L
    J Obstet Gynaecol Res; 2017 Oct; 43(10):1543-1549. PubMed ID: 28714170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a low-cost, low-power syringe pump to deliver magnesium sulfate intravenously to pre-eclamptic women in a Malawian referral hospital.
    Skerrett E; Kommwa E; Maynard K; Juarez A; Mataya R; Richards-Kortum R; Oden ZM
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):191. PubMed ID: 28629437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia.
    Singh J; O'Donovan M; Coulter-Smith SD; Geary M
    J Obstet Gynaecol; 2005 Jan; 25(1):15-7. PubMed ID: 16147685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.
    Duley L; Matar HE; Almerie MQ; Hall DR
    Cochrane Database Syst Rev; 2010 Aug; 2010(8):CD007388. PubMed ID: 20687086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey.
    Long Q; Oladapo OT; Leathersich S; Vogel JP; Carroli G; Lumbiganon P; Qureshi Z; Gülmezoglu AM;
    BJOG; 2017 Nov; 124(12):1883-1890. PubMed ID: 27885772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OS034. Magnesium sulfate for prevention of eclampsia: Are intramuscularand intravenous regimens equivalent?
    Easterling T; Salinger D; Mundle S; Regi A; Bracken H; Winikoff B; Vicini P
    Pregnancy Hypertens; 2012 Jul; 2(3):194. PubMed ID: 26105248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP088. Oral antihypertensive therapy for severe hypertension in pregnancy.
    Firoz T; Magee LA; Lalani S; Sawchuck D; Payne B; Vidler M; Gordon R; von Dadelszen P;
    Pregnancy Hypertens; 2012 Jul; 2(3):288. PubMed ID: 26105410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
    Eddy KE; Vogel JP; Zahroh RI; Bohren MA
    BJOG; 2022 Feb; 129(3):379-391. PubMed ID: 34520111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loading Dose only versus Standard Dose Magnesium Sulfate Seizure Prophylaxis in Severe Pre-eclamptic Women.
    Rimal SP; Rijal P; Bhatt R; Thapa K
    JNMA J Nepal Med Assoc; 2017; 56(208):388-94. PubMed ID: 29453467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia.
    Sibai BM; Lipshitz J; Anderson GD; Dilts PV
    Obstet Gynecol; 1981 Feb; 57(2):199-202. PubMed ID: 7465124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
    Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
    Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study.
    Salinger DH; Mundle S; Regi A; Bracken H; Winikoff B; Vicini P; Easterling T
    BJOG; 2013 Jun; 120(7):894-900. PubMed ID: 23530757
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.